News

Presbyopia affects between 1.09 billion and 1.80 billion people worldwide. ... NEW EYE DROPS TO REMOVE READING GLASSES. The new eye drops PresVu is a non-invasive process to treat presbyopia.
PresVu eye drops, developed at Entod Pharmaceuticals' R&D centre in India, ... Presbyopia is the gradual loss of the eye's ability to focus on nearby objects, explained Mayo Clinic.
LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market ...
Pharmaceutical eye drops provide ‘exciting opportunity’ to personalize presbyopia care By Cecelia Koetting, OD, FAAO, DipABO By Nate Lighthizer, OD, FAAO, FAAOMS ...
Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong ...
This segment is sponsored by Johnson & Johnson.In a breakthough in vision technology, there is now a first-of-its kind, daily ...
Aceclidine-Based Eye Drop Under Review for Presbyopia. Diana Ernst, RPh | Publish Date October 21, 2024 . A PDUFA action date of August 8, 2025 has been assigned to the application. The Food and ...
Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!
ENTOD Pharmaceuticals has recently launched PresVu eye drops, which have been approved by the Drug Controller General of India (DCGI). Marketed as a potential breakthrough for presbyopia — a ...
These drops have been specially developed for people who have presbyopia, an eye-related condition that affects those above the age of 40, according to Network 18. More about PresVu ...
The eye drops were initially approved for treating presbyopia in adults, but this approval was suspended on September 10, by the Central Drugs Standard Control Organization (CDSCO) following what ...